ProBiotix Health Plc (AQU: PBX)
London
· Delayed Price · Currency is GBP · Price in GBX 8.50
+0.50 (6.25%)
At close: Feb 5, 2025
ProBiotix Health Revenue
ProBiotix Health had revenue of 1.01M GBP in the half year ending June 30, 2024, with 233.11% growth. This brings the company's revenue in the last twelve months to 2.13M, up 70.65% year-over-year. In the year 2023, ProBiotix Health had annual revenue of 1.67M with 49.19% growth.
Revenue (ttm)
2.13M
Revenue Growth
+70.65%
P/S Ratio
4.86
Revenue / Employee
303.86K
Employees
7
Market Cap
13.44M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 1.67M | 551.62K | 49.19% |
| Dec 31, 2022 | 1.12M | 21.25K | 1.93% |
| Dec 31, 2021 | 1.10M | 279.01K | 33.98% |
| Dec 31, 2020 | 821.13K | 453.90K | 123.60% |
| Dec 31, 2019 | 367.23K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 38.20B |
| Shell | 227.10B |
| HSBC Holdings | 43.25B |
| Unilever | 51.12B |
| Rio Tinto Group | 42.87B |
| RELX PLC | 9.30B |
| British American Tobacco p.l.c. | 26.18B |
| BP p.l.c. | 144.69B |